[Potential hepatotoxic compounds and mechanisms of Epimedii Folium based on network toxicology and cell experimental

Lin Zhang1, Ting Wang1, Zi-Ying Xu1

  • 1Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine Beijing 100029, China.

Insights

Epimedii Folium may cause liver damage through oxidative stress and apoptosis, with icaritin identified as a key hepatotoxic compound. This study clarifies the herb's potential risks and mechanisms for safe application.

Area of Science:

  • Pharmacology
  • Toxicology
  • Herbal Medicine Research

Background:

  • Epimedii Folium is used in traditional medicine, but its potential hepatotoxicity requires investigation.
  • Understanding the mechanisms of herb-induced liver injury is crucial for patient safety.

Purpose of the Study:

  • To identify hepatotoxic components and elucidate the mechanism of Epimedii Folium using network toxicology and cell experiments.
  • To validate the role of icaritin as a key hepatotoxic compound.

Main Methods:

  • Network toxicology analysis (SwissTargetPrediction, GeneCards, pathway enrichment analyses).
  • Identification of active compounds and targets.
  • In vitro validation using HL-7702 and HepG2 cell lines.

Main Results:

  • Icaritin was identified as the key hepatotoxic compound among 11 active compounds.
  • Network analysis revealed 64 potential hepatotoxic targets and pathways like PI3K-Akt.
  • Cell experiments confirmed icaritin induces hepatotoxicity via oxidative stress and apoptosis.

Conclusions:

  • Epimedii Folium's hepatotoxicity is linked to oxidative stress and apoptosis regulation.
  • Icaritin damages liver cells by disrupting cell membranes, inhibiting antioxidants, and inducing apoptosis.
  • Findings provide insights into the safe use of Epimedii Folium.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
45
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
52
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
664
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
52